The management of childhood asthma in children with poondu ennai.

clinical evaluation of poondu ennai(A siddha drug) in the treatment of suzhi maantham (childhood asthma) in children - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/06/014558

Enrollment

Registered

2018-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Babies with symptoms of Health Condition 2: J454- Moderate persistent asthma Health Condition 3: J454- Moderate persistent asthma

Interventions

Intervention1: Poondu ennai: poondu ennai is a polyherb formulation in a dosage of 5ml bd for 7 days Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: Children of both sexes in the age group of 1 to 3 years with symptoms of: 1 Wheezing, 2 Dyspnoea 3 Intermittent fever 4 In drawing of respiratory muscles 5 Insomnia 6 Refusing the feeding 7 Loss of appetite 8 Fatigue

Exclusion criteria

Exclusion criteria: 1 Long term fever, 2 Active primary complex 3 Congenital heart diseases 4 Lower respiratory tract infections[Pneumonia] 5 Renal disease 6 Any other serious illness

Design outcomes

Secondary

Measure	Time frame
Reduction in the recurrence of the disease and improvement in the quality of life of children.Timepoint: 48days	—

Primary

Measure	Time frame
Efficacy of the trial drug is measured by clinical respiratory scoring system and improvement in the clinical condition is assured.Timepoint: 1-7days	—

Countries

India

Contacts

Public ContactDr M Meenakshi sundaram

National institute of siddha

mmssiddha@rediffmail.com9940266442

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026